These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 24268764)

  • 1. Clinical performance of the novel DiaSorin LIAISON(®) XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays.
    Krawczyk A; Hintze C; Ackermann J; Goitowski B; Trippler M; Grüner N; Neumann-Fraune M; Verheyen J; Fiedler M
    J Clin Virol; 2014 Jan; 59(1):44-9. PubMed ID: 24268764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of the predictive value of the HIV Ag/Ab screening assay within the performance characteristics of the DiaSorin LIAISON XL for the detection of blood-borne viruses.
    Thai KTD; Götz H; Slingerland BCGC; Klaasse J; Schutten M; GeurtsvanKessel CH
    J Clin Virol; 2018 May; 102():95-100. PubMed ID: 29547874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of hepatitis B surface antigen with the novel DiaSorin LIAISON XL Murex HBsAg Quant: correlation with the ARCHITECT quantitative assays.
    Burdino E; Ruggiero T; Proietti A; Milia MG; Olivero A; Caviglia GP; Marietti M; Rizzetto M; Smedile A; Ghisetti V
    J Clin Virol; 2014 Aug; 60(4):341-6. PubMed ID: 24930708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems.
    Sommese L; Sabia C; Paolillo R; Parente D; Capuano M; Iannone C; Cavalca F; Schiano C; Vasco M; De Pascale MR; Casamassimi A; Napoli C
    Scand J Infect Dis; 2014 Sep; 46(9):660-4. PubMed ID: 25073538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Liaison XL automated immunoassay platform for blood-borne infection screening on hepatitis B, hepatitis C, HIV 1/2, HTLV 1/2 and Treponema pallidum serological markers.
    Malm K; Kragsbjerg E; Andersson S
    Transfus Med; 2015 Apr; 25(2):101-5. PubMed ID: 25779614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of LIAISON® XL system for HBsAg, and anti-HCV and anti-HIV/Ag p24.
    De Paschale M; Manco MT; Belvisi L; Cagnin D; Cerulli T; Paganini A; Arpino O; Cianflone A; Agrappi C; Mirri P; Clerici P
    J Med Virol; 2017 Mar; 89(3):489-496. PubMed ID: 27467710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.
    Yang JF; Lin YY; Hsieh MH; Tsai CH; Liu SF; Yu ML; Dai CY; Huang JF; Lin WY; Lin ZY; Chen SC; Chuang WL
    Kaohsiung J Med Sci; 2011 Jul; 27(7):258-63. PubMed ID: 21757142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical performances of simultaneous detection of HIV-1, HIV-2 and hepatitis C- specific antibodies and hepatitis B surface antigen (HBsAg) by multiplex immunochromatographic rapid test with serum samples: A cross-sectional study.
    Robin L; Mboumba Bouassa RS; Nodjikouambaye ZA; Charmant L; Matta M; Simon S; Filali M; Mboup S; Bélec L
    J Virol Methods; 2018 Mar; 253():1-4. PubMed ID: 29208530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of HBsAg mutants in the blood donor population of Pakistan.
    Farooq A; Waheed U; Zaheer HA; Aldakheel F; Alduraywish S; Arshad M
    PLoS One; 2017; 12(11):e0188066. PubMed ID: 29166662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum.
    Wursthorn K; Jaroszewicz J; Zacher BJ; Darnedde M; Raupach R; Mederacke I; Cornberg M; Manns MP; Wedemeyer H
    J Clin Virol; 2011 Apr; 50(4):292-6. PubMed ID: 21273117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis C.
    Ryu JH; Kwon M; Moon JD; Hwang MW; Lee JM; Park KH; Yun SJ; Bae HJ; Choi A; Lee H; Jung B; Jeong J; Han K; Kim Y; Oh EJ
    Ann Lab Med; 2018 Nov; 38(6):578-584. PubMed ID: 30027702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.
    Kania D; Bekalé AM; Nagot N; Mondain AM; Ottomani L; Meda N; Traoré M; Ouédraogo JB; Ducos J; Van de Perre P; Tuaillon E
    Clin Microbiol Infect; 2013 Dec; 19(12):E533-41. PubMed ID: 23902574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
    Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
    J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance comparison of the 4th generation Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA on the EVOLIS™ automated system versus Abbott ARCHITECT HIV Ag/Ab Combo, Ortho Anti-HIV 1+2 EIA on Vitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur.
    Mitchell EO; Stewart G; Bajzik O; Ferret M; Bentsen C; Shriver MK
    J Clin Virol; 2013 Dec; 58 Suppl 1():e79-84. PubMed ID: 24342482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New automated chemiluminescence immunoassay for simultaneous but separate detection of human immunodeficiency virus antigens and antibodies.
    Alonso R; López Roa P; Suárez M; Bouza E
    J Clin Microbiol; 2014 May; 52(5):1467-70. PubMed ID: 24574285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilution.
    Liu TW; Yeh ML; Huang CF; Lin IL; Huang JF; Dai CY; Chen YL; Chuang WL; Yu ML
    Kaohsiung J Med Sci; 2015 Jan; 31(1):26-33. PubMed ID: 25600917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Short communication: comparison of two different assays for the investigation of HBsAG, anti-HCV and anti-HIV in blood donors].
    Cavdar E; Kuştimur S; Doğruman Al F
    Mikrobiyol Bul; 2006 Oct; 40(4):363-7. PubMed ID: 17205694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.
    van Helden J; Denoyel G; Karwowska S; Reamer R; Schmalz J; Wright T; Preisel-Simmons B
    Clin Lab; 2004; 50(1-2):63-73. PubMed ID: 15000222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of occult hepatitis B in HIV infected patients].
    Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S
    Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of circulating HBsAg and anti-HBs antibodies in chronic hepatitis B carriers is not a simple analytical artifact and does not influence HBsAg quantification.
    Pancher M; Désiré N; Ngo Y; Akhavan S; Pallier C; Poynard T; Thibault V
    J Clin Virol; 2015 Jan; 62():32-7. PubMed ID: 25542467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.